Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [4079]

MS-553 shows promise in treating chronic lymphocytic leukaemia

Prof Jennifer Woyach - The Ohio State University, Columbus, USA

MS-553 shows promise in treating chronic lymphocytic leukaemia ( Prof Jennifer Woyach - The Ohio State University, Columbus, USA )

BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer

Dr Wala Ben Kridis - Habib Bourguiba Hospital, Sfax, Tunisia

BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer ( Dr Wala Ben Kridis - Habib Bourguiba Hospital, Sfax, Tunisia )

Enhancing cancer care in Africa: Patient perspectives and quality improvement

Dr Verna Vanderpuye - Korle-Bu Teaching Hospital, Accra, Ghana

Enhancing cancer care in Africa: Patient perspectives and quality improvement ( Dr Verna Vanderpuye - Korle-Bu Teaching Hospital, Accra, Ghana )

Key insights on breast cancer in Cape Verde

Dr Pamela Borges - Agostinho Neto University Hospital, Praia, Cape Verde

Key insights on breast cancer in Cape Verde ( Dr Pamela Borges - Agostinho Neto University Hospital, Praia, Cape Verde )

Addressing cancer control challenges in Africa

Dr Zainab Bagudu - MedicAid Cancer Foundation, Abuja, Nigeria

Addressing cancer control challenges in Africa ( Dr Zainab Bagudu - MedicAid Cancer Foundation, Abuja, Nigeria )

Liso-cel in r/r follicular lymphoma shows durable 3-year responses and...

Dr Sairah Ahmed - MD Anderson Cancer Network, Houston, USA

Liso-cel in r/r follicular lymphoma shows durable 3-year responses and favourable long-term safety ( Dr Sairah Ahmed - MD Anderson Cancer Network, Houston, USA )

TKI chemotherapy and ponatinib improve survival outcomes in blast phase CML

Dr Akriti Jain - Cleveland Clinic, Cleveland, USA

TKI chemotherapy and ponatinib improve survival outcomes in blast phase CML ( Dr Akriti Jain - Cleveland Clinic, Cleveland, USA )

Consolidation treatment delays do not compromise survival in MRD-negative adult...

Prof Bhavana Bhatnagar - WVU Medicine Wheeling Hospital, Wheeling, USA

Consolidation treatment delays do not compromise survival in MRD-negative adult ALL ( Prof Bhavana Bhatnagar - WVU Medicine Wheeling Hospital, Wheeling, USA )

SABCS 2025: Latest developments in multigene testing in early breast cancer

Prof Nadia Harbeck and Prof Giuseppe Curigliano

SABCS 2025: Latest developments in multigene testing in early breast cancer ( Prof Nadia Harbeck and Prof Giuseppe Curigliano )

Gustave Roussy International Egypt: Public private partnership model in cancer...

Dr Ahmed Hassan Abdel Aziz, Dr Yasmine El Hennawii & Dr Nermeen Moustafa

Gustave Roussy International Egypt: Public private partnership model in cancer care ( Dr Ahmed Hassan Abdel Aziz, Dr Yasmine El Hennawii & Dr Nermeen Moustafa )

Higher tumour-infiltrating lymphocytes predict better pathologic response in...

Prof Sunil Badve - Emory University, Atlanta, USA

Higher tumour-infiltrating lymphocytes predict better pathologic response in HER2-positive breast cancer ( Prof Sunil Badve - Emory University, Atlanta, USA )

Dasatinib, prednisone, and blinatumomab combination shows promising outcomes in...

Dr Anjali Advani - Cleveland Clinic, Cleveland, USA

Dasatinib, prednisone, and blinatumomab combination shows promising outcomes in elderly patients with Ph+ ALL ( Dr Anjali Advani - Cleveland Clinic, Cleveland, USA )

More from ecancer